TECH
NASDAQ · Life Sciences Tools & Services
Bio-Techne Corp
$58.88
+2.62 (+4.65%)
Financial Highlights (FY 2026)
Revenue
1.20B
Net Income
71.96M
Gross Margin
66.5%
Profit Margin
6.0%
Rev Growth
+3.3%
D/E Ratio
0.18
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 66.5% | 66.5% | 39.4% | 39.4% |
| Operating Margin | 8.4% | 7.5% | 9.4% | 9.0% |
| Profit Margin | 6.0% | 5.7% | 7.1% | 7.4% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.20B | 1.16B | 4.96B | 3.84B |
| Gross Profit | 795.07M | 769.45M | 1.95B | 1.51B |
| Operating Income | 100.19M | 87.27M | 467.28M | 345.45M |
| Net Income | 71.96M | 62.68M | 349.73M | 285.59M |
| Gross Margin | 66.5% | 66.5% | 39.4% | 39.4% |
| Operating Margin | 8.4% | 7.5% | 9.4% | 9.0% |
| Profit Margin | 6.0% | 5.7% | 7.1% | 7.4% |
| Rev Growth | +3.3% | +3.3% | -8.8% | +23.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 692.88M | 692.88M | 586.61M | 603.00M |
| Total Equity | 3.84B | 3.84B | 6.41B | 5.49B |
| D/E Ratio | 0.18 | 0.18 | 0.09 | 0.11 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 130.92M | 120.37M | 713.51M | 532.70M |
| Free Cash Flow | — | — | 309.30M | 255.34M |